Efficacy and safety of ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma and prior noncellular anti-BCMA therapy: CARTITUDE-2 cohort C
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
relapsed/refractory multiple myeloma,multiple myeloma,ciltacabtagene autoleucel,anti-bcma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要